Literature DB >> 31948982

Successful liver transplantation for drug-induced vanishing bile duct syndrome.

Ahmed Hashim1, Ashley Barnabas2, Rosa Miquel2, Kosh Agarwal2.   

Abstract

Drug-induced cholestasis has a wide range of clinical presentations, and in a small number of patients, it can progress to severe ductopenia. A 63-year-old woman was referred to our department with progressive cholestasis and hyperbilirubinaemia following a course of flucloxacillin. Despite the comprehensive laboratory, imaging and genetic investigations, no other cause for the cholestasis was demonstrated. Sequential liver biopsies confirmed the development of vanishing bile duct syndrome. She developed significant cachexia and pruritus that did not respond to medical therapy, and hence she was listed for liver transplantation. She underwent liver transplantation 6 months after the initial drug-induced injury. She has remained well with good graft function at 1-year follow-up. The case highlights an extreme form of drug-induced ductopenia and underscores the need for meticulous hepatology input and consideration of liver transplantation in some patients. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs and medicines; liver disease; transplantation

Mesh:

Substances:

Year:  2020        PMID: 31948982      PMCID: PMC7035849          DOI: 10.1136/bcr-2019-233052

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Idiopathic adulthood ductopenia: long-term follow-up after liver transplantation.

Authors:  R Rios; J I Herrero; J Quiroga; B Sangro; I Sola; F Pardo; J A Cienfuegos; M Herraiz; J Prieto
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 2.  The role of ondansetron in the management of cholestatic or uremic pruritus--a systematic review.

Authors:  Timothy H M To; Katherine Clark; Lawrence Lam; Tania Shelby-James; David Christopher Currow
Journal:  J Pain Symptom Manage       Date:  2012-06-21       Impact factor: 3.612

3.  Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis.

Authors:  Yu Kawasaki; Kousaku Matsubara; Kimio Hashimoto; Ken Tanigawa; Masayoshi Kage; Aya Iwata; Hiroyuki Nigami; Takashi Fukaya
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-11       Impact factor: 2.839

Review 4.  Idiopathic adulthood ductopenia: an update.

Authors:  J Ludwig
Journal:  Mayo Clin Proc       Date:  1998-03       Impact factor: 7.616

5.  Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.

Authors:  M H Davies; R F Harrison; E Elias; S G Hübscher
Journal:  J Hepatol       Date:  1994-01       Impact factor: 25.083

6.  Idiopathic biliary ductopenia in adults without symptoms of liver disease.

Authors:  A Moreno; V Carreño; A Cano; C González
Journal:  N Engl J Med       Date:  1997-03-20       Impact factor: 91.245

7.  Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump.

Authors:  Ralf Kubitz; Verena Keitel; Sybille Scheuring; Karl Köhrer; Dieter Häussinger
Journal:  J Clin Gastroenterol       Date:  2006-02       Impact factor: 3.062

Review 8.  Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.

Authors:  Jason C White; Stephanie Appleman
Journal:  Pediatrics       Date:  2014-09-22       Impact factor: 7.124

Review 9.  Hodgkin's lymphoma-related vanishing bile duct syndrome: a case report and literature review.

Authors:  Kiong-Ming Wong; Chao-Sung Chang; Chun-Chieh Wu; Hsin-Ling Yin
Journal:  Kaohsiung J Med Sci       Date:  2013-08-09       Impact factor: 2.744

Review 10.  Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.

Authors:  Mena Bakhit; Thomas R McCarty; Sunhee Park; Basile Njei; Margaret Cho; Raffi Karagozian; AnnMarie Liapakis
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

View more
  1 in total

Review 1.  Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature.

Authors:  Joseph William Clinton; Sara Kiparizoska; Soorya Aggarwal; Stephanie Woo; William Davis; James H Lewis
Journal:  Drug Saf       Date:  2021-09-17       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.